News stories about PhotoMedex (NASDAQ:PHMD) have been trending positive recently, according to Accern. The research firm scores the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. PhotoMedex earned a news sentiment score of 0.27 on Accern’s scale. Accern also assigned news headlines about the medical equipment provider an impact score of 44.9309880462034 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

PhotoMedex (PHMD) traded down 9.84% during trading on Tuesday, reaching $1.10. The company’s stock had a trading volume of 7,580 shares. The stock’s market capitalization is $4.66 million. The firm has a 50 day moving average of $0.96 and a 200 day moving average of $1.45. PhotoMedex has a 52 week low of $0.71 and a 52 week high of $5.60.

Separately, ValuEngine raised PhotoMedex from a “strong sell” rating to a “sell” rating in a research note on Friday, June 2nd.

WARNING: This piece of content was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.watchlistnews.com/favorable-press-coverage-somewhat-unlikely-to-impact-photomedex-phmd-stock-price/1490603.html.

PhotoMedex Company Profile

PhotoMedex, Inc is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage. The Company operates through three business segments: Consumer segment, Physician Recurring segment and Professional segment.

Insider Buying and Selling by Quarter for PhotoMedex (NASDAQ:PHMD)

Receive News & Ratings for PhotoMedex Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PhotoMedex Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.